Schering Sun Care Sales Growth Helps Maintain Slippery Market Lead
This article was originally published in The Tan Sheet
Schering-Plough sun care sales increased 8% to $77 mil. in the second quarter, helping the firm maintain its category-leading, albeit slipping, position in the U.S. sunscreen market.
You may also be interested in...
Switching Rx low- and non-sedating, second-generation antihistamines over-the-counter is unlikely to increase out-of-pocket costs for U.S. consumers based upon OTC pricing of the drugs in foreign countries, a health insurance rep told FDA June 29.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning